Due to the alteration of the von Hippel-Lindau (VHL) gene and activation of the Ras-PI3K-AKT-mTOR pathway, the RCC is occasionally considered as a “Metabolic Disease”; besides, the reprogramming of the fatty acid metabolism is one of the most associated pathways (8). Here, MTOR is linked to renal cell adenocarcinoma.